Adverum Biotechnologies, Inc. (ADVM)

Last Year

29-Apr-23 -- 28-Apr-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Reduce

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

35

0

3

+1

0

+2

0

+3

Two Year Chart

29-Apr-22 -- 28-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
09-Feb-24 5:51 PM View:	07-Feb-24 Private Purchase $135.00K	Scopa James Paul Director		Adverum Biotechnologies, Inc. - ADVM	2999% 3.33K to 103.33K	0	0	--	--	Show Txns Hide Txns

09-Feb-24 5:50 PM View:	07-Feb-24 Private Purchase $175.50K	Lupher, Jr. Mark L. Director		Adverum Biotechnologies, Inc. - ADVM	100% 0 to 130.0K	0	0	--	--	Show Txns Hide Txns

18-Sep-23 6:54 PM View:	15-Sep-23 Sale ($9.43K)	Seyedkazemi Setareh Chief Development Officer		Adverum Biotechnologies, Inc. - ADVM	(12%) 53.88K to 47.67K	0	0	--	--	Show Txns Hide Txns

09-Jun-23 4:26 PM View:	07-Jun-23 Private Purchase $145.49K	Rubinstein Linda M Chief Financial Officer		Adverum Biotechnologies, Inc. - ADVM	100% 0 to 100.0K	0	0	--	--	Show Txns Hide Txns